Skip to main content
Clinical Trials/NCT06659601
NCT06659601CompletedNot Applicable

Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection

First Affiliated Hospital of Chongqing Medical University1 site in 1 country9 target enrollmentStarted: June 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
9
Locations
1
Primary Endpoint
Recurrence Prediction Accuracy

Study Overview

Brief Summary

This study aims to develop a deep learning model based on noncontrast CT images to predict the recurrence risk of stage IA invasive lung adenocarcinoma after sub-lobar resection,which can serve as potential tool to assist thoracic surgeons in making optimal treatment decisions.The study will use existing CT data to train and validate the model, without requiring any additional intervention for the participants.

Detailed Description

This study is designed to develop a deep learning model to predict the recurrence risk of stage IA invasive lung adenocarcinoma after sub-lobar resection using noncontrast CT images. The best indications for sub-lobar resection in patients with early-stage LADC are still debated, making surgical method selection somewhat difficult. The deep learning model can noninvasively and objectively predict the recurrence risk of patients with stage IA ILADC following sub-lobectomy and are helpful in predicting prognosis of patients with stage IA ILADC after sub-lobectomy and can facilitate the choosing of the optimal surgery mode of these patients.

The study will utilize retrospective data from patients with stage IA invasive lung adenocarcinoma after sub-lobar resection . Noncontrast CT images will be collected at admission and used as inputs for the deep learning model. The model will be trained using convolutional neural networks (CNN) to identify patterns associated with recurrence.

In addition to model development, the study will also evaluate the model's performance on a separate validation cohort to assess generalizability. Statistical analyses will include performance metrics such as area under the receiver operating characteristic (ROC) curve (AUC) and precision-recall curve.

This study aims to provide a valuable tool for clinicians to make timely decisions in choosing the optimal therapeutic approach.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • (i) pathological confirmation of LADC; (ii) undergoing sub-lobar resection (wedge resection or segmentectomy); (iii) CT scanning prior to surgery; (iv) pathological staging of IA; and (v) complete clinical and follow-up data.

Exclusion Criteria

  • (i) multiple primary LADC; and (ii) other pulmonary lesions that might interfere with the morphological assessment of tumors.

Outcomes

Primary Outcomes

Recurrence Prediction Accuracy

Time Frame: October 2024

The primary outcome measure is the accuracy of the 3D deep learning model in predicting the recurrence of stage IA invasive lung adenocarcinoma after sub-lobar resection. Accuracy will be evaluated by comparing the model's predictions with actual patient outcomes using metrics such as sensitivity, specificity, and area under the ROC curve (AUC).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
First Affiliated Hospital of Chongqing Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xin Fan

Principal Investigator

First Affiliated Hospital of Chongqing Medical University

Study Sites (1)

Loading locations...

Similar Trials

Deep Learning Model to Predict the... | Clinical Trial